• Quick Order
  • Careers
  • Support

2021 News Releases

Exterior of new ATCC building. November 23, 2021

ATCC Announces Award from NIAID to Develop Research Capabilities in Infectious, Immunologic, and Allergic Diseases

ATCC announced that it has been awarded a seven-year contract by NIAID to develop research capabilities in infectious, immunologic, and allergic diseases.

Greg Ballish, headshot October 20, 2021

ATCC Hires New Chief Commercial Officer

ATCC has hired Greg Ballish as its new chief commercial officer. In this role, Ballish will lead ATCC’s sales and marketing operations and help oversee the corporate business and commercial center.

New ATCC building entrance at dusk with lights. September 01, 2021

ATCC Expands Board of Directors with Three Appointments

The ATCC Board of Directors added Melissa Rewolinski, Steve Curts, and Heather Kiessling to advise senior leadership on a variety of business, strategy and science-related issues.

New ATCC building entrance. July 27, 2021

ATCC Bolsters Senior Management Team in Federal Solutions Division

ATCC announces the promotion of Dr. Joseph Leonelli to senior vice president of ATCC Federal Solutions.

New ATCC building entrance. June 29, 2021

ATCC Extends its Leadership Team with Two Key Appointments

ATCC announced that it has made two key appointments within its leadership team.

Green and blue conditionally reprogrammed organoid cells. June 24, 2021

ATCC Expands Commercially Available Collection of Rare Cancer Culture Models

ATCC is expanding its collection of 2-D and 3-D patient tissue-derived in vitro cancer models, including organoids, as part of the Human Cancer Models Initiative to help scientists study cancer and identify and target novel therapies.

Gloved hand holding petri dish containing world map created in the media. April 21, 2021

FDA Virus Stocks Prepared at ATCC Designated as WHO-CBER International Reference Reagents

ATCC announced that five high-quality, concentrated virus preparations that it produced and stored under contract from the FDA/CBER have been designated as international reference reagents for high-throughput sequencing technologies by the World Health Organization.

Red AIDS ribbon on a white background. February 01, 2021

ATCC Announces Award of HIV Reagent Program

ATCC announced that it has been awarded a three-year, $9.86 million task order contract by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to manage and operate its HIV Reagent Program, formerly known as the AIDS Reagent Program.